PMGC Holdings ELAB
NASDAQ ELAB
$2.78 -0.03 (-1.06%)
As of: Oct 21, 2026 · 3:47 PM EDT

PMGC Holdings (ELAB) EBT (2022 - 2026)

Updated

PMGC Holdings (ELAB) reported EBT of -$4.33 million for Q2 2026.

Analysis

PMGC Holdings (ELAB) EBT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, PMGC Holdings' EBT came in at -$13.11 million; for FY2025, it was -$7.75 million.

  • By year, EBT came in at -$4.02 million in FY2024, -$20,339 in FY2023 and -$1.79 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly EBT since Q3 2022.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$3.74 million (Q1 2026), -$2.67 million (Q4 2025) and -$2.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 4.28 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.80 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -653.00 Mn
10 PMGC Holdings 1.36 Mn -47.00 Mn 385,691.00 -4.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.33 Mn
Mar 31, 2026 -3.74 Mn
Dec 31, 2025 -2.67 Mn
Sep 30, 2025 -2.37 Mn
Sep 30, 2024 -1.27 Mn
Jun 30, 2024 -1.43 Mn
Mar 31, 2024 -1.70 Mn
Dec 31, 2023 2.67 Mn
Sep 30, 2023 -791,239.00
Jun 30, 2023 -1.06 Mn
Mar 31, 2023 -841,282.00
Dec 31, 2022 1.11 Bn
Sep 30, 2022 -469.32 Mn
API Access

PMGC Holdings EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ELAB&period=max&api_key=YOUR_API_KEY